IQVIA Holdings Inc. (IQV)

IQV Income Statement

Revenue, expenses, and profitability analysis

IQV Quarterly Income Statement (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Gross Profit	4.343B	1.355B	292.000M	1.373B	1.323B	1.298B	1.378B	1.378B	1.057B
Revenue	16.632B	4.151B	4.364B	4.100B	4.017B	3.829B	3.958B	3.896B	3.814B
Cost of Goods Sold	12.289B	2.796B	4.072B	2.727B	2.694B	2.531B	2.580B	2.518B	2.757B
Gross Profit Margin	32.6%	32.6%	6.7%	33.5%	32.9%	33.9%	34.8%	35.4%	27.7%
Total Operating Expenses	2.038B	841.000M	-440.000M	820.000M	817.000M	802.000M	752.000M	828.000M	509.000M
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	1.993B	502.000M	468.000M	514.000M	509.000M	508.000M	453.000M	522.000M	509.000M
Operating Income (EBIT)	2.305B	514.000M	732.000M	553.000M	506.000M	496.000M	626.000M	550.000M	548.000M
Operating Margin	12.4%	12.4%	16.8%	13.5%	12.6%	13.0%	15.8%	14.1%	14.4%
Income Before Tax (EBT)	1.631B	328.000M	572.000M	408.000M	323.000M	310.000M	549.000M	350.000M	438.000M
Interest Income	40.000M	6.000M	11.000M	13.000M	10.000M	11.000M	11.000M	13.000M	12.000M
Interest Expense	756.000M	192.000M	193.000M	189.000M	182.000M	165.000M	171.000M	170.000M	163.000M
Other Income/Expense	-674.000M	-186.000M	-160.000M	-145.000M	-183.000M	-186.000M	-77.000M	-201.000M	-110.000M
Net Income	1.385B	274.000M	514.000M	331.000M	266.000M	249.000M	437.000M	285.000M	363.000M
Income Tax Expense	250.000M	59.000M	58.000M	76.000M	57.000M	61.000M	112.000M	65.000M	75.000M
Net Profit Margin	6.6%	6.6%	11.8%	8.1%	6.6%	6.5%	11.0%	7.3%	9.5%
EBITDA	3.513B	802.000M	1.047B	883.000M	781.000M	753.000M	1.018B	797.000M	883.000M
EBITDA Margin	19.3%	19.3%	24.0%	21.5%	19.4%	19.7%	25.7%	20.5%	23.2%
Depreciation & Amortization	1.167B	288.000M	317.000M	286.000M	276.000M	265.000M	303.000M	278.000M	269.000M
EPS Basic	8.14	1.63	3.02	1.94	1.55	1.42	2.44	1.57	1.99
EPS Diluted	8.07	1.61	2.99	1.93	1.54	1.40	2.42	1.55	1.97
Shares Outstanding	168.400M	168.400M	170.000M	170.200M	171.800M	175.700M	178.900M	182.100M	182.200M
Diluted Shares Outstanding	169.800M	169.800M	171.900M	171.700M	173.200M	177.400M	180.800M	184.200M	184.300M

IQV Annual Income Statement (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Gross Profit	4.286B	5.375B	5.239B	5.028B	4.641B	3.859B	3.788B	3.666B
Revenue	16.310B	15.405B	14.984B	14.410B	13.874B	11.359B	11.088B	10.412B
Cost of Goods Sold	12.024B	10.030B	9.745B	9.382B	9.233B	7.500B	7.300B	6.746B
Gross Profit Margin	26.3%	34.9%	35.0%	34.9%	33.5%	34.0%	34.2%	35.2%
Total Operating Expenses	1.999B	3.173B	3.262B	3.229B	3.248B	3.128B	3.011B	2.925B
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	1.999B	1.992B	2.053B	2.071B	1.964B	1.789B	1.734B	1.716B
Operating Income (EBIT)	2.287B	2.202B	1.977B	1.799B	1.393B	731.000M	777.000M	741.000M
Operating Margin	14.0%	14.3%	13.2%	12.5%	10.0%	6.4%	7.0%	7.1%
Income Before Tax (EBT)	1.613B	1.669B	1.459B	1.351B	1.134B	380.000M	343.000M	343.000M
Interest Income	45.000M	47.000M	36.000M	13.000M	6.000M	6.000M	9.000M	8.000M
Interest Expense	729.000M	670.000M	672.000M	416.000M	375.000M	416.000M	447.000M	414.000M
Other Income/Expense	-674.000M	-533.000M	-518.000M	-448.000M	-259.000M	-351.000M	-434.000M	-398.000M
Net Income	1.360B	1.373B	1.358B	1.091B	966.000M	279.000M	191.000M	259.000M
Income Tax Expense	252.000M	296.000M	101.000M	260.000M	163.000M	72.000M	116.000M	59.000M
Net Profit Margin	8.3%	8.9%	9.1%	7.6%	7.0%	2.5%	1.7%	2.5%
EBITDA	3.464B	3.453B	3.256B	2.909B	2.767B	2.076B	2.001B	1.883B
EBITDA Margin	21.2%	22.4%	21.7%	20.2%	19.9%	18.3%	18.0%	18.1%
Depreciation & Amortization	1.144B	1.114B	1.125B	1.130B	1.264B	1.287B	1.202B	1.141B
EPS Basic	7.91	7.57	7.39	5.82	5.05	1.46	0.98	1.27
EPS Diluted	7.84	7.49	7.29	5.72	4.95	1.43	0.96	1.24
Shares Outstanding	171.900M	181.300M	183.800M	187.600M	191.400M	191.300M	195.100M	203.700M
Diluted Shares Outstanding	173.500M	183.400M	186.300M	190.600M	195.000M	195.000M	199.600M	208.200M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC

89,000 employees

www.iqvia.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Ari Bousbib

View full financials